Sanders, Novo Nordisk CEO clash over weight loss drug prices

  • Posted on September 24, 2024
  • By The Hill
  • 6 Views
Sanders, Novo Nordisk CEO clash over weight loss drug prices

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite repeatedly being pressed by Senate Health Committee Chair Bernie Sander…
continue reading...

Author
The Hill

You May Also Like